{
  "_originalData": {
    "identity": {
      "bacteriumName": "Campylobacter fetus",
      "aliases": [],
      "lastUpdated": "2025-04-22",
      "clsiCategory": "Other Non-Enterobacterales",
      "classification": {
        "gramStain": "Gram-negative",
        "morphology": "Rod (gull-wing appearance)",
        "respiration": "Microaerophilic",
        "notes": []
      },
      "strainDetails": [],
      "biochemicalTests": "Gram-negative S-shaped rod, microaerophilic, motile, oxidase +, catalase +, grows at 25°C but not 42°C, H2S production in TSI."
    },
    "clinicalProfile": {
      "summary": "Campylobacter fetus is an opportunistic pathogen that primarily causes systemic disease, such as bacteremia and focal infections, in debilitated, immunocompromised, or elderly individuals. While it can be a food-borne illness, diarrhea is an uncommon presentation.",
      "pathophysiologyPearls": [
        "Infection is often associated with exposure to livestock or consumption of contaminated food products.",
        "Tends to cause extraintestinal and systemic infections more commonly than other Campylobacter species."
      ],
      "keySignsAndSymptoms": [
        "Fever",
        "Malaise",
        "Symptoms of bacteremia",
        "Focal signs depending on the site of infection (e.g., meningitis, endocarditis)"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Bacteremia",
          "description": "A common presentation, particularly in immunocompromised hosts."
        },
        {
          "syndromeName": "Meningitis",
          "description": "Can occur, especially in neonates and immunocompromised individuals."
        },
        {
          "syndromeName": "Endovascular Infections",
          "description": "Includes endocarditis and mycotic aneurysms."
        },
        {
          "syndromeName": "Prosthetic Device Infections",
          "description": "Can infect prosthetic joints and other implanted materials."
        },
        {
          "syndromeName": "Gastroenteritis",
          "description": "Uncommon, but can occur."
        }
      ],
      "stagesOfIllness": [],
      "highRiskPopulations": [
        "Immunocompromised hosts (e.g., HIV, malignancy)",
        "Debilitated individuals",
        "Elderly",
        "Pregnant women",
        "Individuals with occupational exposure to animals (e.g., veterinarians, abattoir workers)"
      ],
      "transmissionVectors": [
        "Contaminated food (unpasteurized milk, undercooked meat)",
        "Contact with infected animals (cattle, sheep)"
      ],
      "prognosisNotes": []
    },
    "resistanceProfile": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [],
      "majorMechanisms": [],
      "clinicalAlerts": [
        {
          "alertTitle": "Fluoroquinolone Resistance",
          "details": "Resistance to fluoroquinolones is common. Susceptibility testing is essential if these agents are considered for treatment."
        },
        {
          "alertTitle": "Third-Generation Cephalosporin Resistance",
          "details": "Resistance to third-generation cephalosporins is found in 10-20% of isolates and has been associated with treatment failure in meningitis."
        }
      ]
    },
    "treatment": {
      "generalNotes": [
        "Treatment recommendations are primarily for bacteremia or focal infections, especially in immunocompromised hosts.",
        "Consider a beta-lactam-gentamicin combination for prosthetic valve infections."
      ],
      "drugsToAvoid": [
        {
          "drugOrClass": "Macrolides",
          "condition": "Serious infections",
          "reason": "Not recommended for the treatment of serious infections caused by C. fetus."
        }
      ],
      "adjunctiveTherapies": [],
      "regimens": [
        {
          "context": {
            "type": "Directed",
            "condition": "Bacteremia or Focal Infections",
            "patientPopulation": [
              "Immunocompromised hosts",
              "Debilitated or elderly patients"
            ],
            "isolateSource": "Blood or other sterile sites"
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "7-14 days for uncomplicated bacteremia; at least 4 weeks for endocarditis",
                  "drugs": [
                    {
                      "drugName": "Imipenem-cilastatin",
                      "dose": "500",
                      "route": "IV",
                      "frequency": "q6h",
                      "comments": ""
                    },
                    {
                      "drugName": "Meropenem",
                      "dose": "1",
                      "route": "IV",
                      "frequency": "q8h",
                      "comments": "For meningitis, use Meropenem 2 gm IV q8h for up to 4-6 weeks."
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Alternative",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "7-14 days for uncomplicated bacteremia; at least 4 weeks for endocarditis",
                  "drugs": [
                    {
                      "drugName": "Ampicillin",
                      "dose": "100 mg/kg/day",
                      "route": "IV",
                      "frequency": "divided q6h",
                      "comments": ""
                    },
                    {
                      "drugName": "Gentamicin",
                      "dose": "5 mg/kg",
                      "route": "IV",
                      "frequency": "q24h",
                      "comments": ""
                    },
                    {
                      "drugName": "Ertapenem",
                      "dose": "1",
                      "route": "IV",
                      "frequency": "q24h",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        }
      ]
    },
    "laboratoryProfile": {
      "testingIndications": [
        "Blood cultures and cultures from other relevant sites are necessary for diagnosis.",
        "Susceptibility testing is crucial due to variable resistance patterns."
      ],
      "methodologyNotes": [
        "C. fetus can be difficult to culture and may require special laboratory procedures and prolonged incubation."
      ],
      "recommendedPanel": [],
      "specialTests": [],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    },
    "additionalInformation": {
      "diagnosticNotes": {
        "summary": "",
        "biosafetyWarning": "",
        "methods": []
      },
      "preventionAndScreening": [],
      "treatmentLifecycle": [],
      "antimicrobialStewardship": [],
      "drugSpecificPearls": [],
      "guidelineReferences": [
        {
          "source": "Clinical Infectious Diseases",
          "citation": "Clin Infect Dis 65:1751, 2017",
          "summaryOrNote": "Report on a cluster of intestinal and extraintestinal cases linked to men who have sex with men (MSM)."
        },
        {
          "source": "Clinical Infectious Diseases",
          "citation": "Clin Infect Dis 58:1579, 2014",
          "summaryOrNote": "Review on the epidemiology, clinical manifestations, and difficulty in culturing C. fetus."
        },
        {
          "source": "Medicine (Baltimore)",
          "citation": "Medicine (Baltimore) 95:e2858, 2016",
          "summaryOrNote": "Information on the treatment of C. fetus meningitis."
        },
        {
          "source": "Medicine",
          "citation": "Medicine 89:319, 2010",
          "summaryOrNote": "Information on antimicrobial resistance in C. fetus."
        },
        {
          "source": "Texas Heart Institute Journal",
          "citation": "Tex Heart Inst J 38:584, 2011",
          "summaryOrNote": "Case report on prosthetic valve infection treated with a beta-lactam-gentamicin combination."
        }
      ]
    }
  },
  "_metadata": {
    "originalKeys": [
      "identity",
      "clinicalProfile",
      "resistanceProfile",
      "treatment",
      "laboratoryProfile",
      "additionalInformation"
    ],
    "conversionTimestamp": "2025-07-15T03:16:49.325Z",
    "sourceFormat": "modern"
  },
  "identity": {
    "bacteriumName": {
      "sources": [
        "identity.bacteriumName"
      ],
      "value": "Campylobacter fetus"
    },
    "aliases": {
      "sources": [
        "identity.aliases"
      ],
      "value": []
    },
    "lastUpdated": {
      "sources": [
        "identity.lastUpdated"
      ],
      "value": "2025-04-22"
    },
    "classification": {
      "sources": [
        "identity.classification"
      ],
      "value": {
        "gramStain": "Gram-negative",
        "morphology": "Rod (gull-wing appearance)",
        "respiration": "Microaerophilic",
        "notes": []
      }
    }
  },
  "clinicalInformation": {
    "sources": [
      "clinicalProfile"
    ],
    "value": {
      "summary": "Campylobacter fetus is an opportunistic pathogen that primarily causes systemic disease, such as bacteremia and focal infections, in debilitated, immunocompromised, or elderly individuals. While it can be a food-borne illness, diarrhea is an uncommon presentation.",
      "pathophysiologyPearls": [
        "Infection is often associated with exposure to livestock or consumption of contaminated food products.",
        "Tends to cause extraintestinal and systemic infections more commonly than other Campylobacter species."
      ],
      "keySignsAndSymptoms": [
        "Fever",
        "Malaise",
        "Symptoms of bacteremia",
        "Focal signs depending on the site of infection (e.g., meningitis, endocarditis)"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Bacteremia",
          "description": "A common presentation, particularly in immunocompromised hosts."
        },
        {
          "syndromeName": "Meningitis",
          "description": "Can occur, especially in neonates and immunocompromised individuals."
        },
        {
          "syndromeName": "Endovascular Infections",
          "description": "Includes endocarditis and mycotic aneurysms."
        },
        {
          "syndromeName": "Prosthetic Device Infections",
          "description": "Can infect prosthetic joints and other implanted materials."
        },
        {
          "syndromeName": "Gastroenteritis",
          "description": "Uncommon, but can occur."
        }
      ],
      "stagesOfIllness": [],
      "highRiskPopulations": [
        "Immunocompromised hosts (e.g., HIV, malignancy)",
        "Debilitated individuals",
        "Elderly",
        "Pregnant women",
        "Individuals with occupational exposure to animals (e.g., veterinarians, abattoir workers)"
      ],
      "transmissionVectors": [
        "Contaminated food (unpasteurized milk, undercooked meat)",
        "Contact with infected animals (cattle, sheep)"
      ],
      "prognosisNotes": []
    }
  },
  "resistanceInformation": {
    "sources": [
      "resistanceProfile"
    ],
    "value": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [],
      "majorMechanisms": [],
      "clinicalAlerts": [
        {
          "alertTitle": "Fluoroquinolone Resistance",
          "details": "Resistance to fluoroquinolones is common. Susceptibility testing is essential if these agents are considered for treatment."
        },
        {
          "alertTitle": "Third-Generation Cephalosporin Resistance",
          "details": "Resistance to third-generation cephalosporins is found in 10-20% of isolates and has been associated with treatment failure in meningitis."
        }
      ]
    }
  },
  "treatmentData": {
    "treatmentData": {
      "_treatmentMetadata": {
        "originalFormat": "modern"
      },
      "standardizedRegimens": [
        {
          "regimenId": "modern-0-0-0",
          "extractedFrom": "treatment.regimens[0].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Bacteremia or Focal Infections",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Immunocompromised hosts",
                "Debilitated or elderly patients"
              ],
              "labFindings": "Blood or other sterile sites"
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Imipenem-cilastatin",
              "dose": "500",
              "route": "IV",
              "frequency": "q6h",
              "duration": "7-14 days for uncomplicated bacteremia; at least 4 weeks for endocarditis",
              "comments": "",
              "originalText": "Imipenem-cilastatin 500 IV q6h"
            },
            {
              "drugName": "Meropenem",
              "dose": "1",
              "route": "IV",
              "frequency": "q8h",
              "duration": "7-14 days for uncomplicated bacteremia; at least 4 weeks for endocarditis",
              "comments": "For meningitis, use Meropenem 2 gm IV q8h for up to 4-6 weeks.",
              "originalText": "Meropenem 1 IV q8h"
            }
          ]
        },
        {
          "regimenId": "modern-0-1-0",
          "extractedFrom": "treatment.regimens[0].recommendations[1].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Bacteremia or Focal Infections",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Immunocompromised hosts",
                "Debilitated or elderly patients"
              ],
              "labFindings": "Blood or other sterile sites"
            }
          },
          "preference": "alternative",
          "drugs": [
            {
              "drugName": "Ampicillin",
              "dose": "100 mg/kg/day",
              "route": "IV",
              "frequency": "divided q6h",
              "duration": "7-14 days for uncomplicated bacteremia; at least 4 weeks for endocarditis",
              "comments": "",
              "originalText": "Ampicillin 100 mg/kg/day IV divided q6h"
            },
            {
              "drugName": "Gentamicin",
              "dose": "5 mg/kg",
              "route": "IV",
              "frequency": "q24h",
              "duration": "7-14 days for uncomplicated bacteremia; at least 4 weeks for endocarditis",
              "comments": "",
              "originalText": "Gentamicin 5 mg/kg IV q24h"
            },
            {
              "drugName": "Ertapenem",
              "dose": "1",
              "route": "IV",
              "frequency": "q24h",
              "duration": "7-14 days for uncomplicated bacteremia; at least 4 weeks for endocarditis",
              "comments": "",
              "originalText": "Ertapenem 1 IV q24h"
            }
          ]
        }
      ]
    }
  },
  "laboratoryData": {
    "sources": [
      "laboratoryProfile"
    ],
    "value": {
      "testingIndications": [
        "Blood cultures and cultures from other relevant sites are necessary for diagnosis.",
        "Susceptibility testing is crucial due to variable resistance patterns."
      ],
      "methodologyNotes": [
        "C. fetus can be difficult to culture and may require special laboratory procedures and prolonged incubation."
      ],
      "recommendedPanel": [],
      "specialTests": [],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    }
  },
  "additionalData": {
    "antimicrobialStewardship": {
      "sources": [
        "antimicrobial_stewardship",
        "antimicrobialStewardship"
      ],
      "value": []
    },
    "comments": {
      "preservedStructure": {
        "originalFormat": "object"
      }
    },
    "diagnosis": {
      "sources": [
        "diagnosis"
      ],
      "value": []
    },
    "allOtherKeys": {}
  }
}